Autologous platelet-rich plasma for treating chronic wounds

作者: Maria José Martinez-Zapata , Arturo J Martí-Carvajal , Ivan Solà , José Angel Expósito , Ignasi Bolíbar

DOI: 10.1002/14651858.CD006899.PUB3

关键词:

摘要: Background Autologous platelet-rich plasma (PRP) is a treatment that contains fibrin and high concentrations of growth factors has the potential to aid wound healing. Objectives To determine whether autologous PRP promotes healing chronic wounds. Search methods We searched Cochrane Wounds Group Specialised Register (searched 15 August 2012); The Central Controlled Trials (CENTRAL) (The Library 2012, Issue 8); Ovid MEDLINE (1950 Week 1 (In-Process & Other Non-Indexed Citations, 14, EMBASE (1980 2012 32); EBSCO CINAHL (1982 10 2012) International Clinical Registry Platform (ICTRP)(accessed 22 2012). No date or language restrictions were applied. Selection criteria We included randomised controlled trials (RCTs) compared with placebo alternative treatments for any type in adults. Data collection analysis Two review authors independently assessed each study against inclusion criteria, extracted data risk bias all trials. We calculated ratio (RR) mean difference (MD) time was analysed as survival using hazard (HR). considered heterogeneity significant when I2 >75%. Main results Nine eligible RCTs included, total 325 participants whom 44% women. median number per RCT 26 (range 86). Four recruited people mixed wounds (there caused by more than one aetiology who had several aetiologies same trial), three venous leg ulcers two foot diabetes. length 12 weeks eight 40 weeks). One at low bias, studies remainder being overall unclear bias. proportion completely healed reported seven standard placebo, no statistically between groups, diabetic (RR 1.16; 95% CI 0.57 2.35), (pooled RR 1.02; 0.81 1.27; I2=0% ) 1.85; 0.76 4.51; I2=42%). area epithelialised end intervention wounds, there groups MD -1.94 cm2; -4.74 0.86; I2=47%). percentage results favour group 51.78%; 32.70 70.86; I2= 0%). Wound complications like infection necrosis RCTs, 1.08; 0.31 3.73). Adverse effects treated those not given 1.07; 0.32 3.58; I2=0%). Authors' conclusions There currently evidence suggest value treating wounds. However, current based on small most which are either Well-designed adequately powered clinical needed.

参考文章(111)
David L. Steed, Howard D. Edington, Marshall W. Webster, Recurrence rate of diabetic neurotrophic foot ulcers healed using topical application of growth factors released from platelets. Wound Repair and Regeneration. ,vol. 4, pp. 230- 233 ,(1996) , 10.1046/J.1524-475X.1996.40210.X
Jorge Vas, Manuela Modesto, Camila Mendez, Emilio Perea-Milla, Inmaculada Aguilar, Jesus Manuel Carrasco-Lozano, Vicente Faus, Francisco Martos, Effectiveness of acupuncture, special dressings and simple, low-adherence dressings for healing venous leg ulcers in primary healthcare: study protocol for a cluster-randomized open-labeled trial BMC Complementary and Alternative Medicine. ,vol. 8, pp. 29- 29 ,(2008) , 10.1186/1472-6882-8-29
David M. Powell, Edward Chang, Edward H. Farrior, Recovery from deep-plane rhytidectomy following unilateral wound treatment with autologous platelet gel: a pilot study. Archives of Facial Plastic Surgery. ,vol. 3, pp. 245- 250 ,(2001) , 10.1001/ARCHFACI.3.4.245
Jeffrey A. Niezgoda, Carl C. Van Gils, Robert G. Frykberg, Jason P. Hodde, Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Advances in Skin & Wound Care. ,vol. 18, pp. 258- 266 ,(2005) , 10.1097/00129334-200506000-00012
Nathan B. Menke, Kevin R. Ward, Tarynn M. Witten, Danail G. Bonchev, Robert F. Diegelmann, Impaired wound healing. Clinics in Dermatology. ,vol. 25, pp. 19- 25 ,(2007) , 10.1016/J.CLINDERMATOL.2006.12.005
N. Greppi, L. Mazzucco, G. Galetti, F. Bona, E. Petrillo, C. Smacchia, E. Raspollini, P. Cossovich, R. Caprioli, P. Borzini, P. Rebulla, M. Marconi, Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients Biologicals. ,vol. 39, pp. 73- 80 ,(2011) , 10.1016/J.BIOLOGICALS.2011.01.002
G. Saldalamacchia, E. Lapice, V. Cuomo, E. De Feo, E. D'Agostino, A.A. Rivellese, O. Vaccaro, A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers. Nutrition Metabolism and Cardiovascular Diseases. ,vol. 14, pp. 395- 396 ,(2004) , 10.1016/S0939-4753(04)80029-2
Bo Jørgensen, Tonny Karlsmark, Hanne Vogensen, Lone Haase, Rasmus Lundquist, A Pilot Study to Evaluate the Safety and Clinical Performance of Leucopatch, an Autologous, Additive-Free, Platelet-Rich Fibrin for the Treatment of Recalcitrant Chronic Wounds The International Journal of Lower Extremity Wounds. ,vol. 10, pp. 218- 223 ,(2011) , 10.1177/1534734611426755